G01N 2800/042
Disorders of carbohydrate metabolism
Official title: Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
G01N2800/042 (Disorders of carbohydrate metabolism) appears on 931 US grants and 1,979 published applications in this corpus.
Search patents in G01N- Granted patents
- 931
- Published applications
- 1,979
- Assignees
- 736
- Inventors
- 2,712
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 7 | 0 |
| 1998 | 22 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 4 |
| 2002 | 8 | 26 |
| 2003 | 9 | 468 |
| 2004 | 14 | 48 |
| 2005 | 12 | 74 |
| 2006 | 22 | 66 |
| 2007 | 76 | 69 |
| 2008 | 75 | 47 |
| 2009 | 26 | 70 |
| 2010 | 26 | 95 |
| 2011 | 37 | 88 |
| 2012 | 42 | 82 |
| 2013 | 50 | 75 |
| 2014 | 39 | 71 |
| 2015 | 47 | 77 |
| 2016 | 38 | 74 |
| 2017 | 38 | 61 |
| 2018 | 51 | 96 |
| 2019 | 54 | 76 |
| 2020 | 42 | 70 |
| 2021 | 44 | 58 |
| 2022 | 32 | 41 |
| 2023 | 21 | 39 |
| 2024 | 28 | 41 |
| 2025 | 17 | 33 |
| 2026 | 12 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Continuous glucose monitoring trend-enabled dose calculator25 Aug 2026US 12,714,786 B2Companion Medical, Inc.
- LAMA2, PLXDC2 and MLL4 as novel biomarkers for prediabetes and diabetes18 Aug 2026US 12,710,430 B2Academia Sinica
- Anti-IDE antibodies and uses of same4 Aug 2026US 12,698,344 B2Ramot at Tel-Aviv University Ltd.
- Amino acid, organic compound and oxylipidin biomarkers in blood for macular edema and use thereof16 Jun 2026US 12,656,352 B2Konkuk University Industrial Cooperation Corp.
- Proinsulin peptides for Type 1 Diabetes2 Jun 2026US 12,643,934 B2King's College London
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Diagnosis, monitoring or prognosis of type 2 diabetes, impaired glucose tolerance or prediabetes17 Sep 2026US 2026/0276653 A1FundacióN PúBlica Galega Instituto De InvestigacióN Sanitaria De Santiago De Compostela
- Methods of estimating blood glucose and related systems17 Sep 2026US 2026/0276659 A1The General Hospital Corporation
- Methods of assessing metabolic health17 Sep 2026US 2026/0276661 A1Baker Heart and Diabetes Institute
- Method of using follistatin in type 2 diabetes risk prediction10 Sep 2026US 2026/0266845 A1Lundoch Diagnostics AB
Most cited
By later US patents
- Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles113US 6,964,850 B2Source Precision Medicine, Inc. · 2005
- Enzyme assays for a droplet actuator108US 8,202,686 B2Advanced Liquid Logic, Inc. · 2012
- Method of conducting a droplet based enzymatic assay103US 8,440,392 B2Advanced Liquid Logic, Inc. · 2013
- Secreted and transmembrane polypeptides and nucleic acids encoding the same77US 6,916,648 B2Genentech, Inc. · 2005
- Method for determining insulin sensitivity with biomarkers68US 8,187,830 B2Metabolon, Inc. · 2012